Advanced Oncotherapy Share Discussion Threads

[leonasdad] 28/11/2016 19:59

is there any NHS backed research into tumeric, animal fat, blood/tissue alkaline and occasional sea salt flush therapy and its effects on cancer industry & cells

[sweet karolina] 28/11/2016 19:53

It could all be a miscommunication / language barrier thing, which AVO can clear up with an RNS at 0700. However the RNS at 0700 could be a Nomad resignation and shares suspended. There is nothing anyone can do about their shareholding now.

Something is clearly very wrong. The hospitals have pulled out of their partnership with Sinophi and do not want the machines. There are other machines on the market maybe they have decided to go with something that is more advanced which they know they will get on time. For the agreement between Sinophi and AVO still to be in place (it is the relationship between the hospitals and Sinophi that has been terminated according to Sinophi website and this happened in early Nov so one presumes AVO have known about it for some time), it would have to be a woolly non binding agreement and not the sales order announced. It is clear that Sinophi are not going to waste any time on it until there is something that they would not be wasting hospitals' time discussing.

When the full truth does come out, and it will, at the very least the market is going to have a very different view on the true value of AVO. If I were unlucky enough to be holding AVO I know what I would be doing when the market opens tomorrow, but everyone needs to make their own investing decision. Make no mistake it is an investing decision and:

"Let's hope one day Barnet you don't need to have Radiotherapy through X-rays. Because Proton Therapy isn't available to you."

has absolutely nothing to do with it.

[barnetpeter] 28/11/2016 19:42

"It goes without saying that shares in Advanced are now totally univestable. I discussed this company at length in bearcast today setting a target price of 22p. In light of this latest revelation that target looks far too generous. Timber! - See more at: hxxp://www.shareprophets.com/views/25586/kerboom-gotcha-sinophi-statement-up-throws-massive-spanner-in-advanced-oncotherapy-works-timber#sthash.Z6z87wJ7.dpuf

[john henry] 28/11/2016 19:40

And what will happen to those projects if AVO announce a fully working tested prototype...

[vatnabrekk] 28/11/2016 19:30

Barnet: The Sinophi news article does NOT say that the contract with AVO is terminated. Read it again! It is Sinophi's project with the hospitals that has been terminated. There is no mention whatsoever that they have given up on AVO, in fact it specifically says "... until such time as Advanced Oncotherapy  has a working prototype capable of commercialization.  As this is a new technology, still in the research and development stage, we are unable to predict when this will be achieved."

So it seems that Sinophi are waiting for the testing of the prototype.

[john henry] 28/11/2016 19:28

This is the only company that can bring Proton Therapy to everyone.

[john henry] 28/11/2016 19:26

Let's hope one day Barnet you don't need to have Radiotherapy through X-rays. Because Proton Therapy isn't available to you.

[john henry] 28/11/2016 19:25

If you don't believe they can produce a working prototype, then you should not be invested. If you believe that the technology and the scientist, companies involved can produce a working prototype ( a machine that is certainly is needed in the battle against cancer) then imho it's worth investing.

[john henry] 28/11/2016 19:19

Some of the Proton Therapy centres are to be located at the Chinese Hospitals etc however they will be built and operated by Sinophi healthcare.

[barnetpeter] 28/11/2016 19:10

Yes john henry can you?


"terminated due to delays in the proton therapy machine delivery schedules"


Do you understand this??? The word is terminated.....

verb
past tense: terminated; past participle: terminated

bring to an end.
"he was advised to terminate the contract"
synonyms: bring to an end, end, bring to a close/conclusion, close, conclude, finish, stop, put an end to, put a stop to, wind up, discontinue, break off, cease, cut short, bring to an untimely end, abort;


Or this

The contract announced in October 2015 was in fact not stated to be with Sinophi. It is explicitly stated that the purchase order was received from the China-Japan Union Hospital of Jilin University, through its partnership with Sinophi Healthcare Limited ("Sinophi"). But it is the Hospital that is the customer. Yet in the 25 November 2016 release we are told that Sinophi is the customer and is on the hook although the hospital has walked. Well which is it? Who is the customer?

Keep on buying more stock john henry.... the shorts need to double up here before this really tanks.

[waterloo01] 28/11/2016 19:04

They could rescue this, but they really do need to change their approach/strategy and probably CEO. One would hope the board would be meeting tonight and taking immediate action. Better hope they produce a decent 7am RNS

[john henry] 28/11/2016 18:58

TW will get it right one day, AVO purchase agreement is with Sinophi not the hospitals. That agreement is a bound contract under UK law.The hospitals are simply waiting for a working prototype, if the company can't produce a working prototype then it's is finished anyway. If it does then it's to the moon.

[barnetpeter] 28/11/2016 18:57

Oh just seen that link. Death spiral time and how long will the cash last now that we know the company does not has a working model, has no contracts, no revenue and is years behind on the timetable? Did the former director know any of this when he sold out?

[john henry] 28/11/2016 18:43

What are you F are on about Barnet the prototype isn't complete and tested yet. Expected towards the end of 2016Can you actually read or do any research.

[sweet karolina] 28/11/2016 18:32

AVO could go to 0p very quickly

[vatnabrekk] 28/11/2016 17:29

So now we know the reason for the hospitals cancelling the installations. So why on earth could AVO not have been transparent in their RNS and let us know the reason? Especially as it is hardly a secret, as it's published in Sinophi's web site, so it was going to come out anyway. And AVO's PR people even refused to give the reason when they were asked directly.

This is really bad, very bad. It is treating shareholders with contempt. If I could afford to get out and take the loss I would. But I will stick it out and hope for an increase in the share price in the next year or so.

I still have faith in the technology, but have totally lost faith in the management.

[waterloo01] 28/11/2016 17:00

Oh. They posted this 2 days ago. No wonder the share price crashed. I said in an earlier post, they need to change strategy pronto. Note. EARLIER IN NOVEMBER




UPDATE ON PROTON THERAPY PROJECTS

November 26, 2016

In early November 2016, Sinophi Healthcare’s two project cooperations with China-Japan Union Hospital of Jilin University and Huai’An First People’s Hospital to install Advanced Oncotherapy LIGHT proton therapy machines were terminated due to delays in the proton therapy machine delivery schedules. Sinophi is not looking for other sites for these machines in either Changchun or Huai’An and will look elsewhere.

As a result, Sinophi does not expect there to be any progress with the four Framework Agreements with Chinese hospitals signed in 2015 to use and install Advanced Oncotherapy LIGHT proton therapy machines until such time as Advanced Oncotherapy has a working prototype capable of commercialization. As this is a new technology, still in the research and development stage, we are unable to predict when this will be achieved.

[waterloo01] 28/11/2016 16:37

I dug a little deeper into the directors of Sino UK. Let's just say that some supposedly very clever people (AVO) have signed a contract with a complete non entity.

Companies house search is free via the beta site. Look at other directorships of the 2 China based directors.

[luminoso] 28/11/2016 16:24

Thats exactly my position too, waterloo.

[waterloo01] 28/11/2016 15:45

Better hope that the ex broker is wrong and the orders are with the China company, not the UK entity.

Oddly, I might take a punt at some point, if it can put in a bottom! Still waiting on a bounce from director buys (should they come) but wouldn't risk much.

[gerhart] 28/11/2016 15:38

Cheeeeers Waterloo.

[waterloo01] 28/11/2016 15:34

lse post. Edit: I also read somewhere that Sino UK (who placed the order?) are not really a trading company. Look at companies house returns. To save you the bother.....they are too small to have to file accounts. Two directors, both China based but British citizens! They did file that they have £10k in shareholder funds.

[gerhart] 28/11/2016 15:27

Waterloo where did that come from. Thanks.

It appears to answer one of Tom W's QQQQs in letter to FCA....AVO’s contracts with Sinophi....and are composed under UK law. (not with hospital)

Wish the BOD would come out and make a clear statement clarifying all queries for sake confidence.

[waterloo01] 28/11/2016 15:15

Copied from someone else: See they agree with me that they need a different location for the 1st installation and not be dependant on the vagaries of Harley St, which is not in their own hands

Advanced Oncotherapy (AVO.L, 73.50p) – Speculative Buy
Late Thursday afternoon AVO, the developer of next-generation proton therapy systems for cancer treatment, made two import disclosures regarding prospective installations of its LIGHT system. Firstly, that the building work for the Harley Street site is expected to start in early January with completion of the building works now seen by March 2018. ‎This follows the successful planning permission granted by Westminster Council on 19 October 2016. The Harley Street Proton Treatment Facility will be jointly operated by Circle Health and the Group. Secondly, that AVO has been informed by Sinophi Healthcare Limited, its exclusive partner for the Chinese market, that Sinophi's customers will not now be proceeding with the installation of AVO's LIGHT technology in the hospitals of China-Japan Union Hospital of Jilin University in Changchun and First People's Hospital of Huai'An. AVO confirmed, however, that the orders for the two machines from Sinophi remain in place and as per its agreement Sinophi plus AVO are now assessing other sites in the same cities as well as pursuing other framework agreements in China.

Our view: That’s a bit of a shock! Not so much the planning complication with planning complications at Harley Street, but the fact that the much-heralded Jilin and Huai’An installations will now not be going ahead. Planning, particularly in a sensitive conservation areas like Harley Street, is always a complex and unpredictable process, so having been granted planning permission some slippage with respect to the completion of the expanded building is no massive surprise. Indeed, should it be subject to further delay or restraint, AVO could even consider diverting the first commercial installation to its fall-back site, Pebble Mill in Birmingham, although whether the vendor financing agreement with Metric Capital Partners is sufficiently flexible to accommodate such a revised proposal is uncertain. But what exactly went wrong in China? The finger appears to point at Sinophi, who appears to have placed firm orders for two LIGHT systems on behalf of the two Chinese hospitals, but only on the basis of framework agreements rather than firm conditions. Somehow, the understanding of what actually comprises a legally binding understanding between the two parties appears to have been lost in translation. Whether they, in fact, walked away because AVO could not formally commit to a delivery schedule, lack of confidence in LIGHT, inadequate funding or, perhaps, a wish to instead stick with tried and trusted first generation technology, rather than take a gamble, remains to be seen. Nevertheless, Sinophi is AVO’s customer (rather than the hospitals) and still has two orders in place for which milestone payments have already been made. Its task now, presumably, must be to find new buyers for the systems. AVO’s contracts with Sinophi are composed under UK law,